Micrornas and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy Publisher Pubmed



Mohammadi AH^{1, 2} ; Seyedmoalemi S^{3, 4} ; Moghanlou M⁵ ; Akhlagh SA⁶ ; Talaei Zavareh SA⁷ ; Hamblin MR⁸ ; Jafari A^{9, 10} ; Mirzaei H¹ Show Affiliations
Source: Molecular Neurobiology Published:2022

Abstract

Synaptic plasticity is the ability of synapses to weaken or strengthen over time, in response to changes in the activity of the neurons. It is orchestrated by a variety of genes, proteins, and external and internal factors, especially epigenetic factors. MicroRNAs (miRNAs) are well-acknowledged epigenetic modulators that regulate the translation and degradation of target genes in the nervous system. Increasing evidence has suggested that a number of miRNAs play important roles in modulating various aspects of synaptic plasticity. The deregulation of miRNAs could be associated with pathological alterations in synaptic plasticity, which could lead to different CNS-related diseases. Herein, we provide an update on the role of miRNAs in governing synaptic plasticity. In addition, we also summarize recent researches on the role of miRNAs in drug addiction, and their targets and mechanism of action. Understanding of the way in which miRNAs contribute to synaptic plasticity provides rational clues in establishing the novel biomarkers and new therapeutic strategies for the diagnosis and treatment of plasticity-related diseases and drug addiction. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.